Report Detail
U.S. Markets for Respiratory Care Products
The annual U.S. economic burden of respiratory disease is more than $106 billion. Appropriate therapy can reduce direct healthcare costs as well as indirect costs such as lost worker productivity. The combined U.S. market for respiratory products totalled more than $4.9 billion in 2015, and is expected to climb at a rate of 7% over the forecast period. The sleep apneamanagement products market (including PAP products and accessories) is expected to experience the most dollar sales ($2.2 billion in 2015), as well as the greatest growth over the forecast period (8%). In the blood gas monitoring systems market, the increasing popularity of POC analyzershas led to the rapid emergence of technological innovation, resulting in the introduction of lighter, more compact, less costly systems. POC systems currently account for nearly 40% of the overall U.S. blood gas analyzersmarket.
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the U.S. ventilator systems, blood gas monitoring systems, pulmonary function assessment products, sleep apneamanagement products, and airway management accessories markets.